Sign In
Buy ELTP
$0.360
+0.0150 (+4.35%)
At Close: Jul 06, 2026
Elite Pharmaceuticals Earnings Calls
Jun 30, 2026
(Upcoming)
| Release date | Aug 13, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 10.26% |
Mar 31, 2026
| Release date | Jun 29, 2026 |
| EPS estimate | - |
| EPS actual | $0.0172 |
| Revenue estimate | - |
| Revenue actual | 40.748M |
Dec 31, 2025
| Release date | Feb 17, 2026 |
| EPS estimate | - |
| EPS actual | $0.0100 |
| Revenue estimate | - |
| Revenue actual | 31.589M |
Sep 30, 2025
| Release date | Nov 14, 2025 |
| EPS estimate | - |
| EPS actual | $0.0100 |
| Revenue estimate | 36.322M |
| Revenue actual | 36.322M |
Last 4 Quarters for Elite Pharmaceuticals
Below you can see how ELTP performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Sep 30, 2025
| Release date | Nov 14, 2025 |
| Price on release | $0.673 |
| EPS estimate | - |
| EPS actual | $0.0100 |
| Date | Price |
|---|---|
| Nov 10, 2025 | $0.633 |
| Nov 11, 2025 | $0.646 |
| Nov 12, 2025 | $0.668 |
| Nov 13, 2025 | $0.670 |
| Nov 14, 2025 | $0.673 |
| Nov 17, 2025 | $0.581 |
| Nov 18, 2025 | $0.564 |
| Nov 19, 2025 | $0.579 |
| Nov 20, 2025 | $0.540 |
| 4 days before | 6.21% |
| 4 days after | -19.71% |
| On release day | -13.56% |
| Change in period | -14.73% |
Dec 31, 2025
| Release date | Feb 17, 2026 |
| Price on release | $0.448 |
| EPS estimate | - |
| EPS actual | $0.0100 |
| Date | Price |
|---|---|
| Feb 10, 2026 | $0.440 |
| Feb 11, 2026 | $0.420 |
| Feb 12, 2026 | $0.418 |
| Feb 13, 2026 | $0.440 |
| Feb 17, 2026 | $0.448 |
| Feb 18, 2026 | $0.407 |
| Feb 19, 2026 | $0.393 |
| Feb 20, 2026 | $0.360 |
| Feb 23, 2026 | $0.369 |
| 4 days before | 1.73% |
| 4 days after | -17.52% |
| On release day | -9.05% |
| Change in period | -16.09% |
Mar 31, 2026
| Release date | Jun 29, 2026 |
| Price on release | $0.395 |
| EPS estimate | - |
| EPS actual | $0.0172 |
| Date | Price |
|---|---|
| Jun 23, 2026 | $0.362 |
| Jun 24, 2026 | $0.370 |
| Jun 25, 2026 | $0.385 |
| Jun 26, 2026 | $0.400 |
| Jun 29, 2026 | $0.395 |
| Jun 30, 2026 | $0.365 |
| Jul 01, 2026 | $0.360 |
| Jul 02, 2026 | $0.345 |
| Jul 06, 2026 | $0.360 |
| 4 days before | 9.12% |
| 4 days after | -8.86% |
| On release day | -7.57% |
| Change in period | -0.552% |
Jun 30, 2026
(Upcoming)
| Release date | Aug 13, 2026 |
| Price on release | - |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 29, 2026 | $0.395 |
| Jun 30, 2026 | $0.365 |
| Jul 01, 2026 | $0.360 |
| Jul 02, 2026 | $0.345 |
| Jul 06, 2026 | $0.360 |
Elite Pharmaceuticals Earnings History
Earnings Calendar
FAQ
When is the earnings report for ELTP?
Elite Pharmaceuticals Inc (ELTP) has scheduled its earnings report for Aug 13, 2026 after the markets close.
What is the ELTP price-to-earnings (P/E) ratio?
ELTP P/E ratio as of Jul 06, 2026 (TTM) is 8.62.
What is the ELTP EPS forecast?
The forecasted EPS (Earnings Per Share) for Elite Pharmaceuticals Inc (ELTP) for the first fiscal quarter 2026 is $.
What are Elite Pharmaceuticals Inc's retained earnings?
On its balance sheet, Elite Pharmaceuticals Inc reported retained earnings of $40.75 million for the latest quarter ending Mar 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
